UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 58

Sortiert nach

Oxidative diversification of amino acids and peptides by small-molecule iron catalysis

Nature (London), 2016-09, Vol.537 (7619), p.214-219

2016

Link zum Volltext

Verfügbarkeit prüfen

Late-stage oxidative C(sp 3 )-H methylation

Nature (London), 2020-04, Vol.580 (7805), p.621-627

2020

Link zum Volltext

Verfügbarkeit prüfen

Fluorodecarboxylation for the Synthesis of Trifluoromethyl Aryl Ethers

Angewandte Chemie (International ed.), 2016-08, Vol.55 (33), p.9758-9762

International ed. in English, 2016

Link zum Volltext

Verfügbarkeit prüfen

Enantioselective Single and Dual α‑C–H Bond Functionalization of Cyclic Amines via Enzymatic Carbene Transfer

Journal of the American Chemical Society, 2023-01, Vol.145 (1), p.537-550

2023

Link zum Volltext

Verfügbarkeit prüfen

Cell‐free in vitro reduction of carboxylates to aldehydes: With crude enzyme preparations to a key pharmaceutical building block

Biotechnology journal, 2021-04, Vol.16 (4), p.e2000315-n/a

2021

Link zum Volltext

Verfügbarkeit prüfen

Application of Flow and Biocatalytic Transaminase Technology for the Synthesis of a 1‑Oxa-8-azaspiro[4.5]decan-3-amine

Organic process research & development, 2022-03, Vol.26 (3), p.616-623

2022

Link zum Volltext

Verfügbarkeit prüfen

PF-07059013: A Noncovalent Modulator of Hemoglobin for Treatment of Sickle Cell Disease

Journal of medicinal chemistry, 2021-01, Vol.64 (1), p.326-342

2021

Link zum Volltext

Verfügbarkeit prüfen

Expedient synthesis of novel β-ketoesters from the Mizoroki–Heck coupling of ethyl 3-ethoxyacrylate with aryl and pyridyl halides

Tetrahedron letters, 2013-12, Vol.54 (51), p.7065-7068

2013

Link zum Volltext

Verfügbarkeit prüfen

Synthesis of Spiropiperidine Lactam Acetyl-CoA Carboxylase Inhibitors

Journal of organic chemistry, 2012-11, Vol.77 (22), p.10050-10057

2012

Link zum Volltext

Verfügbarkeit prüfen

Novel and selective spiroindoline-based inhibitors of sky kinase

Bioorganic & medicinal chemistry letters, 2012-01, Vol.22 (1), p.190-193

2012

Link zum Volltext

Verfügbarkeit prüfen

Activation of the G-Protein-Coupled Receptor 119: A Conformation-Based Hypothesis for Understanding Agonist Response

Journal of medicinal chemistry, 2011-03, Vol.54 (6), p.1948-1952

2011

Link zum Volltext

Verfügbarkeit prüfen

Optimization of highly selective 2,4-diaminopyrimidine-5-carboxamide inhibitors of Sky kinase

Bioorganic & medicinal chemistry letters, 2013-02, Vol.23 (4), p.1051-1055

2013

Link zum Volltext

Verfügbarkeit prüfen

Highly selective 2,4-diaminopyrimidine-5-carboxamide inhibitors of Sky kinase

Bioorganic & medicinal chemistry letters, 2013-02, Vol.23 (4), p.1046-1050

2013

Link zum Volltext

Verfügbarkeit prüfen

Intrinsic Electrophilicity of a 4-Substituted-5-cyano-6-(2-methylpyridin-3-yloxy)pyrimidine Derivative: Structural Characterization of Glutathione Conjugates in Vitro

Chemical research in toxicology, 2011-02, Vol.24 (2), p.269-278

2011

Link zum Volltext

Verfügbarkeit prüfen

Fluorodecarboxylation for the Synthesis of Trifluoromethyl Aryl Ethers

Angewandte Chemie, 2016-08, Vol.128 (33), p.9910-9914

2016

Link zum Volltext

Verfügbarkeit prüfen

Exploration of 4,4-disubstituted pyrrolidine-1,2-dicarboxamides as potent, orally active Factor Xa inhibitors with extended duration of action

Bioorganic & medicinal chemistry, 2009-03, Vol.17 (6), p.2501-2511

2009

Link zum Volltext

Verfügbarkeit prüfen

Pyrazole inhibitors of HMG-CoA reductase: An attempt to dramatically reduce synthetic complexity through minimal analog re-design

Bioorganic & medicinal chemistry letters, 2007-10, Vol.17 (20), p.5567-5572

2007

Link zum Volltext

Verfügbarkeit prüfen

Route Optimization of the Non-covalent Modulator of Hemoglobin PF-07059013 for the Treatment of Sickle Cell Disease, Part I: From Discovery Synthesis to First Kilogram-Scale Manufacture

Organic process research & development, 2023-05, Vol.27 (5), p.854-865

2023

Link zum Volltext

Verfügbarkeit prüfen

The discovery of fluoropyridine-based inhibitors of the factor VIIa/TF complex—Part 2

Bioorganic & medicinal chemistry letters, 2006-02, Vol.16 (4), p.1060-1064

2006

Link zum Volltext

Verfügbarkeit prüfen

The discovery of glycine and related amino acid-based factor Xa inhibitors

Bioorganic & medicinal chemistry, 2006-07, Vol.14 (13), p.4379-4392

2006

Link zum Volltext

Verfügbarkeit prüfen

The discovery of fluoropyridine-based inhibitors of the Factor VIIa/TF complex

Bioorganic & medicinal chemistry letters, 2005-11, Vol.15 (21), p.4752-4756

2005

Link zum Volltext

Verfügbarkeit prüfen

Process Development of a Second Generation β‑Amyloid-Cleaving Enzyme InhibitorImproving the Robustness of a Halogen-Metal Exchange Using Continuous Stirred-Tank Reactors

Organic process research & development, 2021-06, Vol.25 (6), p.1440-1453

2021

Link zum Volltext

Verfügbarkeit prüfen

Structure-based Drug Design of Pyrrolidine-1, 2-dicarboxamides as a Novel Series of Orally Bioavailable Factor Xa Inhibitors

Chemical biology & drug design, 2007-06, Vol.69 (6), p.444-450

2007

Link zum Volltext

Verfügbarkeit prüfen

Highly Functionalized Cyclohexenyl Systems: Enzymatic Resolution and Selective Oxirane Opening Reactions of p-Benzoquinone Derivatives

Journal of organic chemistry, 1998-07, Vol.63 (15), p.5088-5093

1998

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 58

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(50)
Mit Volltextzugriff
(54)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(40)
Life Sciences & Biomedicine
(25)
Chemistry
(23)
Physical Sciences
(22)
Chemistry, Organic
(20)
Humans
(20)
Chemistry, Medicinal
(14)
Pharmacology & Pharmacy
(14)
Animals
(12)
Structure-Activity Relationship
(10)
Biological And Medical Sciences
(8)
Medical Sciences
(8)
Pharmacology. Drug Treatments
(8)
Catalysis
(7)
Molecular Structure
(7)
Biochemistry & Molecular Biology
(6)
Rats
(6)
Crystallography, X-Ray
(5)
Inhibitory Concentration 50
(5)
Blood. Blood Coagulation. Reticuloendothelial System
(4)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Oxidative diversification of amino acids and peptides by small-molecule iron catalysis

Late-stage oxidative C(sp 3 )-H methylation

Fluorodecarboxylation for the Synthesis of Trifluoromethyl Aryl Ethers

Enantioselective Single and Dual α‑C–H Bond Functionalization of Cyclic Amines via Enzymatic Carbene Transfer

Cell‐free in vitro reduction of carboxylates to aldehydes: With crude enzyme preparations to a key pharmaceutical building block

Application of Flow and Biocatalytic Transaminase Technology for the Synthesis of a 1‑Oxa-8-azaspiro[4.5]decan-3-amine

PF-07059013: A Noncovalent Modulator of Hemoglobin for Treatment of Sickle Cell Disease

Expedient synthesis of novel β-ketoesters from the Mizoroki–Heck coupling of ethyl 3-ethoxyacrylate with aryl and pyridyl halides

Synthesis of Spiropiperidine Lactam Acetyl-CoA Carboxylase Inhibitors

Novel and selective spiroindoline-based inhibitors of sky kinase

Activation of the G-Protein-Coupled Receptor 119: A Conformation-Based Hypothesis for Understanding Agonist Response

Optimization of highly selective 2,4-diaminopyrimidine-5-carboxamide inhibitors of Sky kinase

Highly selective 2,4-diaminopyrimidine-5-carboxamide inhibitors of Sky kinase

Intrinsic Electrophilicity of a 4-Substituted-5-cyano-6-(2-methylpyridin-3-yloxy)pyrimidine Derivative: Structural Characterization of Glutathione Conjugates in Vitro

Fluorodecarboxylation for the Synthesis of Trifluoromethyl Aryl Ethers

The Discovery of (2R,4R)-N-(4-chlorophenyl)-N- (2-fluoro-4-(2-oxopyridin-1(2H)-yl)phenyl)-4-methoxypyrrolidine-1,2-dicarboxamide (PD 0348292), an Orally Efficacious Factor Xa Inhibitor

Exploration of 4,4-disubstituted pyrrolidine-1,2-dicarboxamides as potent, orally active Factor Xa inhibitors with extended duration of action

Pyrazole inhibitors of HMG-CoA reductase: An attempt to dramatically reduce synthetic complexity through minimal analog re-design

Route Optimization of the Non-covalent Modulator of Hemoglobin PF-07059013 for the Treatment of Sickle Cell Disease, Part I: From Discovery Synthesis to First Kilogram-Scale Manufacture

The discovery of fluoropyridine-based inhibitors of the factor VIIa/TF complex—Part 2

The discovery of glycine and related amino acid-based factor Xa inhibitors

The discovery of fluoropyridine-based inhibitors of the Factor VIIa/TF complex

Process Development of a Second Generation β‑Amyloid-Cleaving Enzyme InhibitorImproving the Robustness of a Halogen-Metal Exchange Using Continuous Stirred-Tank Reactors

Structure-based Drug Design of Pyrrolidine-1, 2-dicarboxamides as a Novel Series of Orally Bioavailable Factor Xa Inhibitors

Highly Functionalized Cyclohexenyl Systems: Enzymatic Resolution and Selective Oxirane Opening Reactions of p-Benzoquinone Derivatives

Suchergebnisse filtern